Suppr超能文献

神经源性高血压犬肾皮质切片中激肽释放酶分泌、激肽释放酶排泄与β-肾上腺素能受体之间的关系

Relationships between kallikrein secretion, kallikrein excretion and beta-adrenoceptors in kidney cortical slices from neurogenic hypertensive dogs.

作者信息

Damase-Michel C, Bompart G, Durrieu G, Montastruc J L, Montastruc P, Girolami J P

机构信息

Laboratoire de Pharmacologie Médicale et Clinique, INSERM U317, Toulouse, France.

出版信息

Br J Pharmacol. 1995 Sep;116(1):1704-10. doi: 10.1111/j.1476-5381.1995.tb16395.x.

Abstract
  1. Sinoaortic denervation (SAD) in dogs is characterized by an increase in blood pressure and heart rate as well as the development of renal morphological lesions similar to those observed in essential hypertension in human subjects. To assess the effect of SAD on the secretion of kallikrein kinin systems (KKS), we studied the in vitro secretion of kallikrein by renal cortical slices of normal and neurogenic hypertensive dogs (1 and 18 months after SAD). The method using renal cortical slices allowed the study of secretion of kallikrein independently of renal perfusion pressure. The number of renal beta-adrenoceptors was measured by [125I]-cyanopindolol binding. 2. SAD was associated with a marked increase in urinary kallikrein excretion at one month and a significant decrease at 18 months when compared with controls. Both changes were statistically significant (P < 0.05). Concurrently, a progressive increase in in vitro kallikrein secretion was observed (+80 +/- 10% and +179 +/- 48%, 1 and 18 months after SAD, respectively). Moreover, the cortical slices obtained from sinoaortic denervated dogs contained more kallikrein than the control cortical slices (+32 +/- 16% and +55 +/- 7%, 1 and 18 months after SAD, respectively). 3. Renal beta-adrenoceptor number significantly (P < 0.05) decreased 18 months after SAD from 18 +/- 2 to 8 +/- 3 fmol mg-1 protein without any change in affinity constant. 4. Although there was no test of association, because the number of renal beta-adrenoceptors decreased whereas kallikrein secretion increased, the present data could suggest a beta-adrenoceptor-mediated inhibition of kallikrein secretion. These results show that although the urinary kallikrein is decreased, the tissue secretory capacities are enhanced. This could suggest a renal compensatory mechanism possibly involved in tissue protection in dogs after SAD, although such a mechanism is not sufficient to reverse hypertension.
摘要
  1. 犬的窦主动脉去神经支配(SAD)的特征是血压和心率升高,以及出现与人类原发性高血压中观察到的类似的肾脏形态学病变。为了评估SAD对激肽释放酶激肽系统(KKS)分泌的影响,我们研究了正常犬和神经源性高血压犬(SAD后1个月和18个月)肾皮质切片中激肽释放酶的体外分泌。使用肾皮质切片的方法可以独立于肾灌注压来研究激肽释放酶的分泌。通过[125I]-氰吲哚洛尔结合来测量肾β-肾上腺素能受体的数量。2. 与对照组相比,SAD在1个月时尿激肽释放酶排泄显著增加,而在18个月时显著减少。这两种变化均具有统计学意义(P<0.05)。同时,观察到体外激肽释放酶分泌逐渐增加(SAD后1个月和18个月分别增加+80±10%和+179±48%)。此外,从窦主动脉去神经支配犬获得的皮质切片比对照皮质切片含有更多的激肽释放酶(SAD后1个月和18个月分别增加+32±16%和+55±7%)。3. SAD后18个月,肾β-肾上腺素能受体数量从18±2显著(P<0.05)降至8±3 fmol mg-1蛋白,亲和力常数无任何变化。4. 尽管没有进行关联性检验,但由于肾β-肾上腺素能受体数量减少而激肽释放酶分泌增加,目前的数据可能提示β-肾上腺素能受体介导的激肽释放酶分泌抑制。这些结果表明,尽管尿激肽释放酶减少,但组织分泌能力增强。这可能提示一种肾脏代偿机制可能参与了犬SAD后的组织保护,尽管这种机制不足以逆转高血压。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验